Puerarin inhibits β‑amyloid peptide 1‑42‑induced tau hyperphosphorylation via the Wnt/β‑catenin signaling pathway

Yao,Ying; Chen,Xianchun; Bao,Yuting; Wu,Yangsheng

doi:10.3892/mmr.2017.7702

December-2017 Volume 16 Issue 6

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

December-2017 Volume 16 Issue 6

Full Size Image

Article

Puerarin inhibits β‑amyloid peptide 1‑42‑induced tau hyperphosphorylation via the Wnt/β‑catenin signaling pathway

Authors:
- Ying Yao
- Xianchun Chen
- Yuting Bao
- Yangsheng Wu
View Affiliations / Copyright

Affiliations: Department of Pharmacy, Hangzhou Medical College, Hangzhou, Zhejiang 310053, P.R. China, Department of Pharmacy, Zhejiang University Hospital, Hangzhou, Zhejiang 310012, P.R. China, Department of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China
Pages: 9081-9085
|
Published online on: October 3, 2017

https://doi.org/10.3892/mmr.2017.7702
Expand metrics +

Abstract

Excessive tau protein phosphorylation is important in the pathogenesis and early abnormal signal transduction of Alzheimer's disease. Excessive phosphorylation of microtubules is associated with tau accumulation, which induces the formation of neurofibrillary tangles in neurons, leading to synaptic damage and ultimately, neurodegeneration. The present study aimed to investigate the possible mechanism underlying the inhibitory effects of puerarin on β‑amyloid peptide (Aβ)1‑42‑induced tau protein hyperphosphorylation in SH‑SY5Y cells. Following various treatments, the viability of SH‑SY5Y cells was determined using the MTT assay, and cell morphology was observed under an inverted fluorescence microscope. Western blotting was used to detect tau phosphorylation, and the protein expression levels of glycogen synthase kinase (GSK)‑3β, phosphorylated (p)‑GSK‑3β (Ser9), β‑catenin and cyclin D1, which are the key factors mediating the Wnt/β‑catenin signaling pathway in SH‑SY5Y cells. The results demonstrated that puerarin reversed the Aβ1‑42‑induced decrease in SH‑SY5Y cell viability. In addition, puerarin inhibited the degree of Aβ1‑42‑induced tau phosphorylation at Ser396, Ser199 and Thr231 in SH‑SY5Y cells, and reduced the expression of GSK‑3β by increasing the expression of p‑GSK‑3β (Ser9). Furthermore, puerarin increased the protein expression levels of β‑catenin and cyclin D1, which are key factors involved in the Wnt/β‑catenin signaling pathway. The results of the present study demonstrated that puerarin may attenuate Aβ1‑42‑induced tau hyperphosphorylation in SH‑SY5Y cells, by inhibiting the expression of GSK‑3β and activating the Wnt/β‑catenin signaling pathway; therefore, puerarin may exert protective effects against Alzheimer's disease.

View Figures

View References

1	Inestrosa NC, Montecinos-Oliva C and Fuenzalida M: Wnt signaling: Role in Alzheimer disease and schizophrenia. J Neuroimmune Pharmacol. 7:788–807. 2012. View Article : Google Scholar : PubMed/NCBI
2	Silva-Alvarez C, Arrázola MS, Godoy JA, Ordenes D and Inestrosa NC: Canonical Wnt signaling protects hippocampal neurons from Ab oligomers: Role of non-canonical Wnt-5a/Ca(2+) in mitochondrial dynamics. Front Cell Neurosci. 7:972013. View Article : Google Scholar : PubMed/NCBI
3	Peng Y and Wang XL: Tau protein and Alzheimers disease. Chin Pharmacol Bull. 20:601–605. 2004.
4	Engel T, Hernández F, Avila J and Lucas JJ: Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3. J Neurosci. 26:5083–5090. 2006. View Article : Google Scholar : PubMed/NCBI
5	Zou Y, Hong B, Fan L, Zhou L, Liu Y, Wu Q, Zhang X and Dong M: Protective effect of puerarin against beta-amyloid-induced oxidative stress in neuronal cultures from rat hippocampus: Involvement of the GSK-3b/Nrf2 signaling pathway. Free Radic Res. 47:55–63. 2013. View Article : Google Scholar : PubMed/NCBI
6	Lin F, Xie B, Cai F and Wu G: Protective effect of Puerarin on b-amyloid-induced neurotoxicity in rat hippocampal neurons. Arzneimittelforschung. 62:187–193. 2012. View Article : Google Scholar : PubMed/NCBI
7	Zhang HY, Hu HT, Liu YH, Wang HQ, Feng GF and Chen GM: Effect of puerarin on PC12 cells apoptosis induced by Abeta25-35 in vitro. Zhong Yao Cai. 31:543–546. 2008.(In Chinese). PubMed/NCBI
8	Nie JW, Li Y and Wang RT: Protective effect of puerarin on PC-12 cell impairment induced by Aβ25-35. Chin J Gerontol. 27:2283–2285. 2007.(In Chinese).
9	Yan FL, Guo L, Wang YQ and Hong Z: Effects of puerarin on the expression of Aβ1-40 and Bax in brain of AD rats. Chin J Neuromed. 5:158–161. 2006.
10	Yan FL, Wang YQ and Guo L: Effects of Puerarin on protein expression of hyperphosphorylated tau and ChAT in hippocampus of Alzheimer's disease rats. J Clin Neurol. 19:191–193. 2006.
11	Steinhilb ML, Dias-Santagata D, Fulga TA, Felch DL and Feany MB: Tau phosphorylation sites work in concert to promote neurotoxicity in vivo. Mol Biol Cell. 18:5060–5068. 2007. View Article : Google Scholar : PubMed/NCBI
12	Léger J, Kempf M, Lee G and Brandt R: Conversion of serine to aspartate imitates phosphorylation-induced changes in the structure and function of microtubule-associated protein tau. J Biol Chem. 272:8441–8446. 1997. View Article : Google Scholar : PubMed/NCBI
13	Xie H, Litersky JM, Hartigan JA, Jope RS and Johnson GV: The interrelationship between selective tau phosphorylation and microtubule association. Brain Res. 798:173–183. 1998. View Article : Google Scholar : PubMed/NCBI
14	Olivieri G, Baysang G, Meier F, Müller-Spahn F, Stähelin HB, Brockhaus M and Brack C: N-acetyl-L-cysteine protects SHSY5Y neuroblastoma cells from oxidative stress and cell cytotoxicity: Effects on beta-amyloid secretion and tau phosphorylation. J Neurochem. 76:224–233. 2001. View Article : Google Scholar : PubMed/NCBI
15	Rapoport M and Ferreira A: PD98059 prevents neurite degeneration induced by fibrillar beta-amyloid in mature hippocampal neurons. J Neurochem. 74:125–133. 2000. View Article : Google Scholar : PubMed/NCBI
16	Frame S, Cohen P and Biondi RM: A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol Cell. 7:1321–1327. 2001. View Article : Google Scholar : PubMed/NCBI
17	Zhang QG, Wang R, Khan M, Mahesh V and Brann DW: Role of Dickkopf-1, an antagonist of the Wnt/beta-catenin signaling pathway, in estrogen-induced neuroprotection and attenuation of tau phosphorylation. J Neurosci. 28:8430–8441. 2008. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Puerarin inhibits β‑amyloid peptide 1‑42‑induced tau hyperphosphorylation via the Wnt/β‑catenin signaling pathway

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Related Articles